Jazz Pharmaceuticals Director Files Form 144 Notice of Proposed Sale

Summary of Proposed Transaction

On August 31, 2026, Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc ($JAZZ), submitted a Form 144 notice of proposed sale covering 2,506 ordinary shares with an aggregate market value of approximately $612,817.00.

Key Details

• Securities to be Sold: 2,506 Common Shares
• Aggregate Market Value: $612,817.00 (~$244.54 per share)
• Acquisition Date & Method: Acquired on August 28, 2026, via restricted stock vesting as equity compensation from the issuer.
• Broker: E*TRADE Financial Corporation
• Shares Outstanding: 64,914,577

Prior 3-Month Sales History

Over the preceding three months, the reporting person has executed consistent monthly sales:

• August 3, 2026: 6,000 shares for gross proceeds of $1,517,880.00
• July 1, 2026: 6,000 shares for gross proceeds of $1,442,820.00
• June 1, 2026: 6,000 shares for gross proceeds of $1,410,720.00

Market Impact & Interpretation

The proposed transaction represents less than 0.01% of total outstanding shares and corresponds directly to newly vested restricted stock units. Given the regular cadence of sales and modest relative transaction volume, the trading significance is considered Low.